A device to reduce left ventricle afterload in a target blood vessel in a mammal includes a cushion configured for positioning within a lumen of the target blood vessel and receipt of a fluid and configured to contract during systole and expand during diastole, a reservoir having a cavity for receiving the fluid, and a conduit extending between and fluidically coupling the cushion and the reservoir, whereby during use fluid in the cushion is transferred to the reservoir during systole and returned to the cushion during diastole. The cushion has an annular cross section defining a central lumen for blood flow and is configured for positioning in the lumen of the target vessel abutting an inner wall of the target vessel, whereby during use blood flow is directed through the central lumen of the cushion.

A device to reduce left ventricle afterload in a target blood vessel in a mammal includes a cushion configured for positioning within a lumen of the target blood vessel and receipt of a fluid and configured to contract during systole and expand during diastole, a reservoir having a cavity for receiving the fluid, and a conduit extending between and fluidically coupling the cushion and the reservoir, whereby during use fluid in the cushion is transferred to the reservoir during systole and returned to the cushion during diastole. The cushion has an annular cross section defining a central lumen for blood flow and is configured for positioning in the lumen of the target vessel abutting an inner wall of the target vessel, whereby during use blood flow is directed through the central lumen of the cushion.

Some embodiments of a system or method for treating heart tissue can include a control system and catheter device operated in a manner to intermittently occlude a heart vessel for controlled periods of time that provide redistribution of blood flow. In particular embodiments, the system and methods may be configured to monitor at least one input signal detected at a coronary sinus and thereby execute a process for determining a satisfactory time period for the occlusion of the coronary sinus. In further embodiments, after the occlusion of the coronary sinus is released, the control system can be configured to select the duration of the release phase before the starting the next occlusion cycle.

A control device (100) for controlling the rotational speed (n.sub.VAD(t)) of a non-pulsatile ventricular assist device, VAD, (50) uses an event-based within-a-beat control strategy, wherein the control device is configured to alter the rotational speed of the VAD within the cardiac cycle of the assisted heart and to synchronize the alteration of the rotational speed with the heartbeat by at least one sequence of trigger signals (σ(t)) that is related to at least one predetermined characteristic event in the cardiac cycle. Further, a VAD (50) for assistance of a heart comprises the control device (100) for controlling the VAD, wherein the VAD is preferably a non-pulsatile rotational, for example catheter-based, blood pump.

The present invention is generally related to methods and systems for preventing onset or worsening of RHF in patients with implanted ventricular assist devices. More particularly, the present invention relates to identifying patients at risk for RHF following implantation of a ventricular assist device based on pulmonary artery pressure measurement and/or trends and adjusting a pump operating parameter to prevent or reduce the onset or worsening of RHF in such patients, improve patient outcomes, or reduce mortality risks associated with VAD implantation. In particular, a pump operating parameter may be adjusted to reduce or minimize particularly high pressure loads on a patient’s heart or amount of time the patient is exposed to such high pressure loads following implantation.

The present invention is generally related to methods and systems for preventing onset or worsening of RHF in patients with implanted ventricular assist devices. More particularly, the present invention relates to identifying patients at risk for RHF following implantation of a ventricular assist device based on pulmonary artery pressure measurement and/or trends and adjusting a pump operating parameter to prevent or reduce the onset or worsening of RHF in such patients, improve patient outcomes, or reduce mortality risks associated with VAD implantation. In particular, a pump operating parameter may be adjusted to reduce or minimize particularly high pressure loads on a patient’s heart or amount of time the patient is exposed to such high pressure loads following implantation.

The systems and methods described herein determine metrics of cardiac or vascular performance, such as cardiac output, and can use the metrics to determine appropriate levels of mechanical circulatory support to be provided to the patient. The systems and methods described determine cardiac performance by determining aortic pressure measurements (or other physiologic measurements) within a single heartbeat or across multiple heartbeats and using such measurements in conjunction with flow estimations or flow measurements made during the single heartbeat or multiple heartbeats to determine the cardiac performance, including determining the cardiac output. By utilizing a mechanical circulatory support system placed within the vasculature, the need to place a separate measurement device within a patient is reduced or eliminated. The system and methods described herein may characterize cardiac performance without altering the operation of the heart pump (e.g., without increasing or decreasing pump speed).

The systems and methods described herein determine metrics of cardiac or vascular performance, such as cardiac output, and can use the metrics to determine appropriate levels of mechanical circulatory support to be provided to the patient. The systems and methods described determine cardiac performance by determining aortic pressure measurements (or other physiologic measurements) within a single heartbeat or across multiple heartbeats and using such measurements in conjunction with flow estimations or flow measurements made during the single heartbeat or multiple heartbeats to determine the cardiac performance, including determining the cardiac output. By utilizing a mechanical circulatory support system placed within the vasculature, the need to place a separate measurement device within a patient is reduced or eliminated. The system and methods described herein may characterize cardiac performance without altering the operation of the heart pump (e.g., without increasing or decreasing pump speed).

A ventricular assist device is provided, including a blood pump, a driveline and a feedthrough. The blood pump includes a pump housing, an axi-symmetric oval-shaped blood sac and stem assembly received in the pump housing, and a pressure sensing system embedded in the pump housing. The driveline includes a pneumatic lumen, at least one electric wire and a tether included in a wall of the driveline, wherein the electric wires and the tether are disposed on the pneumatic lumen. The feedthrough connects the driveline to the pump housing.

A ventricular assist device is provided, including a blood pump, a driveline and a feedthrough. The blood pump includes a pump housing, an axi-symmetric oval-shaped blood sac and stem assembly received in the pump housing, and a pressure sensing system embedded in the pump housing. The driveline includes a pneumatic lumen, at least one electric wire and a tether included in a wall of the driveline, wherein the electric wires and the tether are disposed on the pneumatic lumen. The feedthrough connects the driveline to the pump housing.